NRC Health (NRC) Stock Score, Valuation & Financial Research
NRC Health is in the Healthcare sector and Medical - Healthcare Information Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 22/100.
Quick answer for NRC
NRC Health currently has a Wall Street Score of 22/100. The stored market price is $21.96. Its financial score is 23/100. Its valuation score is 4/100. These figures are a research snapshot, not a buy or sell recommendation.
What NRC Health does
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk
NRC financial snapshot
- Wall Street Score:
- 22/100
- Current price:
- $21.96
- Market capitalization:
- $494.9M
- Revenue:
- $138.6M
- Net income:
- $9.0M
- Free cash flow:
- $15.7M
- Cash:
- $2.5M
- Total debt:
- $78.0M
- EPS:
- 0.52
- P/E ratio:
- 42.2x
- Financial score:
- 23/100
- Valuation score:
- 4/100
- Revenue score:
- 8/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $15.7M, showing positive cash generation.
- The balance sheet shows $2.5M of cash versus $78.0M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 4/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 23/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research NRC
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.